Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,285
datasets available to search
ShareScore release 0.9.0
Dataset results
2,285 results for “T-cells”
A Phase I Trial of Tumor-Associated Lymph Node T-Cell Injection With Advanced Malignant Solid Tumors
ClinicalTrials.gov study NCT06716619. IPD Sharing: NO. Countries: 1. Publications: 0.
Using T-Cell Alloreactivity and Chimerism to Guide Immunosuppression Minimization in Intestinal Transplantation
ClinicalTrials.gov study NCT04804891. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
A Phase II Study of the Combination of Ponatinib With Mini-hyper CVD Chemotherapy and Venetoclax in Patients With Relapsed or Refractory T-cell Acute Lymphoblastic Leukemia
ClinicalTrials.gov study NCT05268003. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of JNJ-80948543, a T-cell Redirecting CD79b x CD20 x CD3 Trispecific Antibody, in Participants With Non-Hodgkin Lymphoma (NHL) and Chronic Lymphocytic Leukemia (CLL)
ClinicalTrials.gov study NCT05424822. IPD Sharing: YES. Countries: 8. Publications: 0.
Different Molecular Subtypes of Peripheral T-cell Lymphoma, a Real-world Registry Study. (TRUST)
ClinicalTrials.gov study NCT05934864. IPD Sharing: NO. Countries: 1. Publications: 0.
A Phase I Trial to Establish the Safety and Maximum Tolerated Dose of High-affinity Autologous BCMA-targeting Chimeric Antigen Receptor (CAR) T-cells in Patients With Relapsed and Refractory B-cell Ma
ClinicalTrials.gov study NCT05836896. IPD Sharing: Not stated. Countries: 1. Publications: 0.
In Vitro Evaluation of Immune Responses in Cutaneous T-Cell Lymphoma (CTCL)
ClinicalTrials.gov study NCT00177190. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Minimal Residual Disease-based Strategy with T-Cell Redirector After Treatment with Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone (D-VRd) in Newly Diagnosed Multiple Myeloma
ClinicalTrials.gov study NCT06353022. IPD Sharing: Not stated. Countries: 1. Publications: 0.
CAR T-cell Therapy Targeting CD19 and BCMA in Patients With B Cell Mediated Autoimmune Disease
ClinicalTrials.gov study NCT07305116. IPD Sharing: NO. Countries: 1. Publications: 0.
Study of CTO1681 for the Prevention and Treatment of CRS in DLBCL Patients Receiving CAR T-Cell Therapy
ClinicalTrials.gov study NCT05905328. IPD Sharing: NO. Countries: 1. Publications: 0.
Forodesine (BCX-1777) in Treating Patients With Refractory Stage IIA, Stage IIB, Stage III, Stage IVA, or Stage IVB Cutaneous T-Cell Lymphoma
ClinicalTrials.gov study NCT00098332. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Clinical Study on the Safety and Efficacy of Autologous CD84 Chimeric Antigen Receptor T-Cell Therapy for Adult Relapsed/Refractory Acute Myeloid Leukemia.
ClinicalTrials.gov study NCT06786299. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Imaging Tumor-infiltrating T-cells in Non-small Cell Lung Cancer
ClinicalTrials.gov study NCT03853187. IPD Sharing: NO. Countries: 1. Publications: 0.
Prospective Evaluation of T-cell Immune Status in Patients With Newly Diagnosed High Grade Gliomas
ClinicalTrials.gov study NCT02041611. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Nivolumab in mRCC Patients: Treg Function, T-cell Access and NK Interactions to Predict and Improve Efficacy
ClinicalTrials.gov study NCT03891485. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Doxycycline for the Treatment of Cutaneous T-Cell Lymphoma
ClinicalTrials.gov study NCT02341209. IPD Sharing: YES. Countries: 1. Publications: 0.
Efficacy and Safety of Lenalidomide Plus CHOP vs CHOP in Patients With Untreated Peripheral T-Cell Lymphoma
ClinicalTrials.gov study NCT04922567. IPD Sharing: NO. Countries: 1. Publications: 0.
Combination Chemotherapy and Nelarabine in Treating Patients With T-cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
ClinicalTrials.gov study NCT00501826. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Epigenetic Regulation of Altered T-cell Immunity in Sarcoidosis
ClinicalTrials.gov study NCT03145922. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of Clinical Outcomes in Patients With Relapsed/Refractory Multiple Myeloma (RRMM) Treated With T-cell Redirectors Outside of Clinical Trials
ClinicalTrials.gov study NCT06285318. IPD Sharing: NO. Countries: 11. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.